<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Continuous kidney replacement therapy solutions: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Continuous kidney replacement therapy solutions: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Continuous kidney replacement therapy solutions: Drug information</div><div class="clear"></div><div id="topicText">For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F5929284"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Phoxillum B22K4/0;</li>
<li>Phoxillum BK4/2.5;</li>
<li>PrismaSol B22GK 4/0;</li>
<li>PrismaSol BGK 0/2.5;</li>
<li>PrismaSol BGK 2/0;</li>
<li>PrismaSol BGK 2/3.5;</li>
<li>PrismaSol BGK 4/0/1.2;</li>
<li>PrismaSol BGK 4/2.5;</li>
<li>PrismaSol BK 0/0/1.2</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F5929287"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Dialysis Solution;</li>
<li>
                        Renal Replacement Solution</li></ul></div>
<div class="block doa drugH1Div" id="F5929368"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="04d6c3c0-fc57-49d1-a87d-524f00fd671f">Continuous renal replacement circuit</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Continuous renal replacement circuit:</b> Pre- or post-hemofilter or hemodiafilter: Volume of solution administered depends upon the patient's clinical condition and fluid, electrolyte, acid-base, and glucose balance.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50992137"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50989368"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dop drugH1Div" id="F5929367"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="04d6c3c0-fc57-49d1-a87d-524f00fd671f">Continuous renal replacement circuit</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Continuous renal replacement circuit:</b> Infants, Children, and Adolescents: Refer to adult dosing.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51090012"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">No dosage adjustment necessary.</p></div>
<div class="block dohp drugH1Div" id="F51090013"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments in manufacturer’s labeling. In patients with hepatic impairment, the ability to convert lactate salts to bicarbonate may be impaired; use caution and monitor closely.</p></div>
<div class="block adr drugH1Div" id="F5929343"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified. Reactions listed are based on reports for other agents in this same pharmacologic class (renal replacement therapy solutions).</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Hypotension</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Acid-base imbalance, electrolyte disorder (including hyperphosphatemia, hypophosphatemia, and increased ionized serum calcium), fluid volume disorder, metabolic acidosis</p></div>
<div class="block coi drugH1Div" id="F5929289"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F5929290"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Fluid and electrolyte imbalances: Multiple electrolyte and volume abnormalities may occur (Fall 2010). Monitor hemodynamic status, fluid input/output, potassium, phosphorous, other electrolytes, and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately.</p>
<p style="text-indent:-2em;margin-left:4em;">• Glucose abnormalities: Solutions may increase the risk for hyperglycemia or hypoglycemia depending on the dextrose content of the replacement solution; abnormalities may require initiation of or modification of antidiabetic therapy during treatment. Adjusting solutions or rates of administration may cause changes in dextrose delivery. Monitor blood glucose regularly.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Anticoagulants: Citrate, when used as an anticoagulant, can contribute to the base load and cause hypocalcemia.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form</i></b>
<b>
<i> specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hydrogen phosphate: Phoxillum replacement solutions contain hydrogen phosphate (a weak acid) and may increase the risk of metabolic acidosis.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Administer only under the direction of a health care provider competent in intensive care treatment, including CRRT. Use only with extracorporeal dialysis equipment appropriate for CRRT.</p></div>
<div class="block dosfc drugH1Div" id="F49507816"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;">Strength presented in the Dosage Forms field represents the final solution after mixing.</p></div>
<div class="block foc drugH1Div" id="F5929374"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Phoxillum B22K4/0: Bicarbonate 22 mEq/L, chloride 122 mEq/L, magnesium 1.5 mEq/L, phosphate 1 mmol/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Phoxillum BK4/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 114.5 mEq/L, magnesium 1.5 mEq/L, phosphate 1 mmol/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol B22GK 4/0: Bicarbonate 22 mEq/L, chloride 120.5 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BGK 2/0: Bicarbonate 32 mEq/L, chloride 108 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BGK 4/0/1.2: Bicarbonate 32 mEq/L, chloride 110.2 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.2 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BGK 0/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 109 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BGK 2/3.5: Bicarbonate 32 mEq/L, calcium 3.5 mEq/L, chloride 111.5 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1 mEq/L, potassium 2 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BGK 4/2.5: Bicarbonate 32 mEq/L, calcium 2.5 mEq/L, chloride 113 mEq/L, dextrose 100 mg/dL, lactate 3 mEq/L, magnesium 1.5 mEq/L, potassium 4 mEq/L, sodium 140 mEq/L (5000 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">PrismaSol BK 0/0/1.2: Bicarbonate 32 mEq/L, chloride 106.2 mEq/L, lactate 3 mEq/L, magnesium 1.2 mEq/L, sodium 140 mEq/L (5000 mL)</p></div>
<div class="block geq drugH1Div" id="F50047948"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F26116539"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol B22GK 4/0 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">22-4 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BGK 0/2.5 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-2.5 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BGK 2/0 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-2 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BGK 2/3.5 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-2-3.5 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BGK 4/0/1.2 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-4-1.2 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BGK 4/2.5 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-4-2.5 mEq/L (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (PrismaSol BK 0/0/1.2 Extracorporeal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">32-1.2 mEq/L (per mL): $0.02</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F5929370"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Ensure separate compartments are mixed completely prior to use. Administer into the extracorporeal circuit before (pre-dilution) the hemofilter or hemodiafilter; after (post-dilution) the hemofilter or hemodiafilter; or before and after the hemofilter or hemodiafilter.</p></div>
<div class="block admp drugH1Div" id="F52614266"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Continuous renal replacement circuit: Ensure separate compartments are mixed completely prior to use. Administer into the extracorporeal circuit before (predilution) the hemofilter or hemodiafilter; after (post-dilution) the hemofilter or hemodiafilter; or before and after the hemofilter or hemodiafilter.</p></div>
<div class="block use drugH1Div" id="F5929288"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Continuous renal replacement circuit:</b> Used as a replacement solution in continuous renal replacement therapy (CRRT) to replace water and to correct electrolyte and acid-base imbalances; in drug poisoning when CRRT is used to remove  dialyzable substances (Phoxillum and PrismaSol only)</p></div>
<div class="block mst drugH1Div" id="F5977832"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">High alert medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error. </p></div>
</div>
</div>
<div class="block pri drugH1Div" id="F28000552"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted. Administration to pregnant women with appropriate monitoring would not be expected to cause harm to the fetus.</p></div>
<div class="block brc drugH1Div" id="F28000554"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">These products are excreted in breast milk. Administration to a lactating woman with appropriate monitoring would not be expected to cause harm to the nursing infant.</p></div>
<div class="block mop drugH1Div" id="F5929372"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Hemodynamic status; fluid, electrolyte and acid-base balance; serum glucose. Concentrations of certain dialyzable drugs may need to be monitored and appropriate therapy implemented to correct for removal during CRRT.</p></div>
<div class="block pha drugH1Div" id="F5929363"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Replacement fluids achieve fluid and electrolyte balance by substituting for the ultrafiltrate removed during some forms of CRRT. Replacement solutions may vary in composition and may include a buffer and electrolytes to manage acid-base disorders and electrolyte imbalances.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F50168874"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Prism0cal b22</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-Duosol.1">
<a name="Duosol.1"></a>Duosol (renal replacement solution) [prescribing information]. Bethlehem, PA: B. Braun Medical Inc. https://www.bbraunusa.com/en/products/b/duosol.html. Accessed June 10, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21166876">
<a name="21166876"></a>Fall P and Szerlip HM. Continuous renal replacement therapy: cause and treatment of electrolyte complications.<i> Semin Dial.</i> 2010;23(6):581-585.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/continuous-kidney-replacement-therapy-solutions-drug-information/abstract-text/21166876/pubmed" id="21166876" target="_blank">21166876</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NxStage.1">
<a name="NxStage.1"></a>NxStage Pureflow B Solutions (renal replacement solution) [prescribing information]. Lawrence, MA: NxStage Medical Inc. https://www.nxstage.com/hcp/products/pureflow-b-solution. Accessed June 10, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-PrimasolPhoxillum.1">
<a name="PrimasolPhoxillum.1"></a>Primasol and Phoxillum (renal replacement solution) [prescribing information]. Deerfield, IL: Baxter Healthcare Corporation; May 2023.</div>
</li></ol></div><div id="topicVersionRevision">Topic 8851 Version 116.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
